MSTR insider exercises options at $69.12, sells shares near $200
Rhea-AI Filing Summary
Strategy Inc's EVP and General Counsel, a reporting officer of MSTR, reported option exercises and related stock sales under a prearranged Rule 10b5-1 trading plan. On November 14, 2025, he exercised 2,600 employee stock options at an exercise price of $69.123 per share for Class A common stock, then sold 2,600 shares at $200.48 per share, leaving 32,726 Class A common shares directly owned. On November 17, 2025, he repeated this pattern, exercising another 2,600 options at $69.123 and selling 2,600 shares at $200 per share, with direct ownership again shown as 32,726 Class A shares.
After these transactions, he also reports direct holdings of 500 shares of Series A Perpetual Strife Preferred Stock, 15,000 shares of Series A Perpetual Stretch Preferred Stock, and 3,527 shares of Series A Perpetual Stride Preferred Stock. The filing notes that these trades occur as he prepares to retire effective December 31, 2025, consistent with a previously disclosed retirement plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 2,600 | $0.00 | -- |
| Exercise | Class A Common Stock | 2,600 | $69.123 | $180K |
| Sale | Class A Common Stock | 2,600 | $200.00 | $520K |
| Exercise | Employee Stock Option (Right to buy) | 2,600 | $0.00 | -- |
| Exercise | Class A Common Stock | 2,600 | $69.123 | $180K |
| Sale | Class A Common Stock | 2,600 | $200.48 | $521K |
| holding | Series A Perpetual Strife Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stretch Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stride Preferred Stock | -- | -- | -- |
Footnotes (1)
- The transactions reported were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on July 11, 2025. As previously disclosed in Strategy Inc's Current Report on Form 8-K filed with the Securities and Exchange Commission on July 1, 2025, the reporting person informed the issuer of his intention to retire effective December 31, 2025. The 2,600 shares exercised on November 14, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 178,798 shares subject to this option, 28,798 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025. The 2,600 shares exercised on November 17, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 176,198 shares subject to this option, 26,198 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025.
FAQ
What insider transactions did MSTR's EVP & General Counsel report on this Form 4?
The EVP & General Counsel of Strategy Inc (MSTR) reported exercising 2,600 employee stock options and selling 2,600 Class A common shares on November 14, 2025, and again exercising 2,600 options and selling 2,600 shares on November 17, 2025.
Were these MSTR trades made under a Rule 10b5-1 trading plan?
Yes. The filing states that the transactions were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on July 11, 2025.
What is the connection between these transactions and the executive's retirement from MSTR?
The explanation notes that the reporting person had previously informed Strategy Inc of his intention to retire effective December 31, 2025, and these trades occur pursuant to that plan as disclosed in an earlier Form 8-K.
What preferred stock holdings of Strategy Inc does the insider report?
The officer reports direct ownership of 500 shares of Series A Perpetual Strife Preferred Stock, 15,000 shares of Series A Perpetual Stretch Preferred Stock, and 3,527 shares of Series A Perpetual Stride Preferred Stock.
How many employee stock options on MSTR stock remain after these transactions?
The Form 4 shows 178,798 employee stock options beneficially owned after the November 14, 2025 exercise and 176,198 options after the November 17, 2025 exercise, each with an exercise price of $69.123 and an expiration date of February 23, 2031.